Company news

Anagenics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

FY23 Financial Performance and Business Update

June 27, 2023

CEO Appointment

March 28, 2023

Results of Institutional Entitlement Offer

February 15, 2023

Entitlement Offer and Company Update

February 13, 2023

Corporate Update and Acquisition

December 8, 2022

FY2022 Annual Report

December 4, 2022

Appendix 4E and FY22 Financial Report

August 24, 2022

Advangen Japan Divestment and Earn-Out Agreement

July 25, 2022

Appointment of Exec Director, Corporate and Trading Update

July 7, 2022

Appendix 4C and Quarterly Activity Report

April 27, 2022

New Leadership Driving Business Transformation

March 15, 2022

Anagenics Appoints CEO

February 28, 2022

Anagenics Board and Leadership Transition

February 15, 2022

Second Supply Agreement for Anagenics FGF5 Inhibitors

December 23, 2021

BLC Cosmetics Acquisition Completed

November 1, 2021

Investor Webinar

September 26, 2021

HNG: BLC Cosmetics to merge with Cellmid

September 15, 2021

Cellmid to Acquire BLC Cosmetics Pty Ltd

September 15, 2021

Appendix 4E and FY21 Financial Report

August 19, 2021

Cellmid Reports Record QVC Sales

June 16, 2021

Supply Agreement for Cellmids FGF5 Inhibitors

June 8, 2021

Chinese Import Permits Received

April 30, 2021

Agreement Signed for Sale of Lyramid Limited

April 29, 2021

Supplementary Prospectus

March 31, 2021

Rights Issue Closed with Strong Demand

March 31, 2021

Rights Issue Prospectus

March 8, 2021

Rights Issue

March 7, 2021

Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer

February 8, 2021

Cellmid Receives First Order From Chinese Distributor

January 24, 2021

Cellmid Signs 10 Year Chinese Distribution Agreement

December 13, 2020

Growth Strategy Presentation

November 11, 2020

FY20 Financial Results

August 27, 2020

Appendix 4E and FY20 Financial Report

August 27, 2020

CDY Signs Agreement With Premium Salon Distributor in USA

July 28, 2020

Response to ASX Aware Query

July 9, 2020

Cellmid Signs Exclusive Agreement For Sars-Cov-2 Laboratory

July 8, 2020

Extension Of Wondfo Rapid Test Distribution Agreement

July 2, 2020

Cellmid Reports on Strong QVC Sales Event

June 15, 2020

Cellmid Reports on Results of The Doherty Institute Testing

June 14, 2020

CDY signs Introducer Agreement to broaden product offering

June 4, 2020

Appointment of Dr Dominic Burg as Chief Operating Officer

June 1, 2020

Cellmids Alopecia Patent Allowed in Australia and Japan

April 24, 2020

Independent Test Results For The Wondfo SARS-CoV-2 Test

April 22, 2020

Cellmids Shipment of SARS-CoV-2 Tests Received

April 14, 2020

Reinstatement to Official Quotation

April 7, 2020

Response to ASX Query Letter

April 6, 2020

Market Update on COVID-19

March 27, 2020

Appendix 4D, Half Year Accounts and Presentation

February 26, 2020

Cellmids Evolis Patent to be Granted in China

February 3, 2020

Appendix 4C and Notes to Appendix 4C

January 29, 2020

← Newer news releases · Older news releases →

Decks

The 5 newest of 24 decks. Every deck is listed under its year.